Newron Prescription drugs S.p.A. (NWPHF) This autumn 2025 Earnings Name Transcript
Newron Prescription drugs S.p.A. (NWPHF) This autumn 2025 Earnings Name March 24, 2026 9:30 AM EDT
Firm Contributors
Stefan Weber – CEO & Government Director
Ravi Anand – Chief Medical Officer
Roberto Galli – Chief Monetary Officer
Convention Name Contributors
Raghuram Selvaraju – H.C. Wainwright & Co, LLC, Analysis Division
Joris Zimmermann – Octavian AG, Analysis Division
Arron Aatkar – Edison Funding Analysis Restricted
Joseph Hedden – Rx Securities Restricted, Analysis Division
Presentation
Operator
Women and gents, welcome to the 2025 Outcomes and 2026 Outlook Convention Name. I’m Mathilde, the Refrain Name operator. [Operator Instructions] The convention is being recorded. [Operator Instructions] The convention should not be recorded for publication or broadcast. Right now, it is my pleasure at hand over to Stefan Weber, CEO. Please go forward.
Stefan Weber
CEO & Government Director
Thanks, Mathilde, and good afternoon, everyone in Europe. Good night, everyone in Asia, and good morning and early 6:30, have a great beginning to the day from Dana Level, California. As standard previously years, we’re unfold over the world. The one individual proper now in our Milan workplaces is the CFO as he must be. He is sitting on the cash that we have to spend within the upcoming interval. Our Chief Medical Officer, Ravi Anand, is correct now making ready for the SIRS, Schizophrenia Worldwide Analysis Society Convention that begins tomorrow. And I’m attending the convention of ROTH Capital at Dana Level. So welcome to this name.
I hope you’ve got had an opportunity to obtain the slide deck that we’re going to information you thru, and I’ll begin with Slide #4. So if we glance again on the final 15 months and the interval that we’re reporting about, and I’ll then do the outlook for ’26 and hand over to Ravi for the brand new science and
